ID   BT142
AC   CVCL_D718
DR   cancercelllines; CVCL_D718
DR   Cosmic; 1629581
DR   Cosmic; 2012330
DR   Wikidata; Q54798487
RX   PubMed=22166263;
RX   PubMed=33504762;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=22166263).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C4050; Oligoastrocytoma
DI   ORDO; Orphanet_251656; Oligoastrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=22166263; DOI=10.1093/neuonc/nor207;
RA   Luchman H.A., Stechishin O.D.M., Dang N.H., Blough M.D.,
RA   Chesnelong C., Kelly J.J.P., Nguyen S.A., Chan J.A.W., Weljie A.M.,
RA   Cairncross J.G., Weiss S.;
RT   "An in vivo patient-derived model of endogenous IDH1-mutant glioma.";
RL   Neuro-oncol. 14:184-191(2012).
//
RX   PubMed=33504762; DOI=10.1038/s41467-020-20752-6;
RA   Lita A., Pliss A., Kuzmin A., Yamasaki T., Zhang L.-M., Dowdy T.,
RA   Burks C., de Val N., Celiku O., Ruiz-Rodado V., Nicoli E.-R.,
RA   Kruhlak M., Andresson T., Das S., Yang C.-Z., Schmitt R.,
RA   Herold-Mende C., Gilbert M.R., Prasad P.N., Larion M.;
RT   "IDH1 mutations induce organelle defects via dysregulated
RT   phospholipids.";
RL   Nat. Commun. 12:614.1-614.16(2021).
//